FNB Pediatric Hemato-Oncology: Admissions, Medical Colleges, fees, eligibility criteria

FNB Paediatric Haemato-Oncology or Fellow of National Board in Paediatric Haemato-Oncology also known as FNB in Paediatric Haemato-Oncology is a doctoral fellowship program for doctors in India that is done by them after completion of their postgraduate medical degree course. The duration of the FNB course is for 2 years.

FNB Paediatric Haemato-Oncology encompasses a broad array of disorders of children and adolescents with Primary immunodeficiency disorders, solid tumours, hematological cancers, and non-malignant disorders of the blood and blood-forming tissues.

The course is a full-time course pursued at various accredited institutes/hospitals across the country, the top institutions include Sir Ganga Ram Hospital, Rajiv Gandhi Cancer Institute, Research Centre, New Delhi, and more.

Candidates can get admission to 2 years FNB course after successfully qualifying for the FET (Fellowship Entrance Test) examination which NBEMS conducts. FET is conducted annually as per the prescribed schedule. The merit-based counselling for admissions to the FNB Programme after the conduct of FET is administered by NBEMS.

The fee for pursuing FNB Paediatric Haemato-Oncology varies from accredited institute/hospital to hospital and is Rs.1,25,000 per year.

After completion of their respective course, doctors can join the job market. Candidates can take reputed jobs at positions as research fellows, Senior residents, Consultants, etc. with an approximate average salary range of Rs. 22 lakhs to Rs. 46 lakhs per year.

The Nomenclature of the FNB qualification awarded by the National Board of Examinations in Medical Sciences is “Fellow of National Board”. The FNB qualifications are recognized qualifications in terms of the Gazette notification dated 10th August 2016.

What is FNB in Paediatric Haemato-Oncology?

FNB in Paediatric Haemato-Oncology is a two-year doctoral fellowship program that candidates can pursue after completing a postgraduate degree.

The main goal of the Paediatric Haemato-Oncology fellowship is to provide the clinical experience and educational opportunities necessary to build a solid foundation of medical knowledge, critical thinking abilities, literature review, diagnostic acumen and technical skills.

The field of Pediatric Haematology-Oncology encompasses a broad array of disorders of children and adolescents with Primary immunodeficiency disorders, solid tumours, hematological cancers, and non-malignant disorders of the blood and blood-forming tissues.

The National Board of Examinations (NBE) has released a curriculum for FNB Paediatric Haemato-Oncology.

The curriculum governs the education and training of FNB Paediatric Haemato-Oncology.

Course Highlights

Here are some of the course highlights of FNB Paediatric Haemato-Oncology

Name of Course	FNB Paediatric Haemato-Oncology
Level	Fellowship
Duration of Course	Two years
Course Mode	Full Time
Minimum Academic Requirement	Candidates must have a postgraduate medical Degree in DNB/MD Paediatrics obtained from any college/university recognized by the Medical Council of India (Now NMC)/NBE. The feeder qualification mentioned here is as of 2022. For any further changes to the prerequisite requirement please refer to the NBE website
Admission Process / Entrance Process / Entrance Modalities	Entrance Exam (FET) Merit-based counselling administered by NBEMS
Course Fees	Rs.1,25,000 per year
Average Salary	Rs. 22 lakhs to Rs.46 lakhs per year

Eligibility Criteria

The eligibility criteria for FNB in Paediatric Haemato-Oncology are defined as the set of rules or minimum prerequisites that aspirants must meet to be eligible for admission, which includes:

Name of Fellowship course	Course Type	Prior Eligibility Requirement
Paediatric Haemato-Oncology	FNB	DNB/MD Paediatrics

Note:

· The feeder qualification for FNB Paediatric Haemato-Oncology is defined by the NBE and is subject to changes in the NBE.

· The feeder qualification mentioned here is as of 2022.

· For any changes, please refer to the NBE website.

· There is no upper age limit for training in NBEMS Fellowship courses.

Admission Process

The admission process contains a few steps to be followed for the candidates for admission to FNB. Candidates can view the complete admission process for FNB Paediatric Haemato-Oncology mentioned below:

Fees Structure

The fee structure for FNB Paediatric Haemato-Oncology varies from accredited institute/hospital to hospital. The fee is generally less for Government Institutes and more for private institutes. The average fee structure for FNB Paediatric Haemato-Oncology is Rs.1,25,000 per year.

Colleges offering FNB Paediatric Haemato-Oncology

Various accredited institutes/hospitals across India offer courses for pursuing FNB Paediatric Haemato-Oncology.

As per the National Board of Examinations website, the following accredited institutes/hospitals are offering (FNB Paediatric Haemato-Oncology) courses for the academic year 2022-23.

Syllabus

FNB in Paediatric Haemato-Oncology is a two years specialization course that provides training in the stream of Paediatric Haemato-Oncology.

The course content for FNB Paediatric Haemato-Oncology is given in the NBE Curriculum released by the National Board of Examinations, which can be assessed through the link mentioned below:

Haematology

• Physiology of Hemostasis and Hematopoiesis

• Classification & Diagnosis of Anemia during Childhood

• Anemia During the Neonatal Period

• Erythroblastosis Fetalis

• Iron-Deficiency Anemia

Megaloblastic Anemia

• Hematologic Manifestations of Systemic Illness

• Bone Marrow Failure syndromes including Acquired Marrow failure

• Hemolytic Anemia due to Membrane & Enzyme Defects

• Hemoglobinopathies…. Sickle Cell Disease/ Thalassemia

• Extracorpuscular Hemolytic Disease (AIHA etc)

• Polycythemia

• Disorders of White Blood Cell

• Disorders of Platelets

• Hemostatic Disorders

• Thrombotic Disorders

• Lymphadenopathy and Splenomegaly

• Porphyrias

• Diagnostic Methodologies in Pediatric Hematology

• Various National Health Programme in Anemia

Transfusion Medicine

• Indications for transfusion of various components

• Methods of preparation of components

• Cryopreservation of Stem Cells

• Transfusion Reactions

• Transfusion Transmitted Diseases

Oncology

• Main Objective: To understand the epidemiology, molecular and cellular biology of various tumours.

Chemotherapy

• Main objective: To know the mechanism of action, indications, toxicities and management of chemotherapeutic agents used in patients with malignancies.

i. Principles of chemotherapy

a) Principles of combination chemotherapy

b) Principles of drug resistance

c) Specific agents

ii. Immunologic Abnormalities

Main Objective: To know the management of infections in immunocompromised patients.

 Bacterial Prophylaxis

 Fungal Prophylaxis

 Viral Prophylaxis

 Treatment of infection in immunocompromised patients

 Early Warning Signs of Cancer in Children/ Models for Early Diagnosis

 Procedures in Pediatric Oncology: Practical Guidelines

iii. Cancer

• Etiopathogenesis of cancer

• Epidemiology of cancer

o Age-related incidence

o Race-related incidence

o Genetic factors

o Chemical-related factors

o Environmental factors

o Immunologic factors

• Tumor molecular and cellular biology factors

• Oncogenesis and cell growth regulation factors

o Lymphoproliferative Disorders

o Myelodysplastic Syndromes

o Myeloproliferative Disorders

o Leukemias

o Histiocytosis Syndromes

o Hodgkin's Disease

o Non-Hodgkin Lymphoma

o Central Nervous System Malignancies

o Neuroblastoma

o Wilms' Tumor

o Rhabdomyosarcoma & Other Soft Tissue Sarcomas

o Malignant Bone Tumors and Osteosarcoma

o Retinoblastoma

o Germ Cell Tumors

o Primary Hepatic Tumors

o Gonadal/ Germ cell tumors

o Rare Tumors

o Tumors in adolescents and young adult

o HLH

o Hematopoietic Stem Cell Transplantation

iv. Rationale, principles, and procedures of Hematopoietic stem cell transplant

• Oncological, haematological, Immunological, metabolic, and autoimmune diseases which are correctable with the transplant procedure

• Rationale for transplant for a given disease or disease status, such as for high-risk malignant disease

• Urgency of the workup of a patient with a diagnosis of severe aplastic anaemia, and the identification of a suitable histocompatible sibling donor

so that transplant procedure can be undertaken as soon as possible before multiple transfusions are given

• Pre-transplant evaluation process (to evaluate organ function) to determine the suitability of an individual patient to undergo a transplant procedure

• Methods in which transplant recipients are conditioned for the transplant procedure, as well as the rationale for the specific transplant conditioning regimen and design of the conditioning regimen

• Sources of hematopoietic stem/progenitor cells available for the procedure of stem cell transplant, as well as the rationale for the selection of a particular source of stem cell product

• Process of acquisition and procurement of stem cells, as well as the rationale and the procedures utilized for the processing of the stem cells before the transplant procedure

• Immunosuppressive therapy for the prevention of graft versus host disease, graft rejection the mode of administration of these agents, as well as their respective benefits and side effects

• Acute, delayed, and chronic complications associated with the transplant procedure and management of these complications, i.e. acute and chronic GvHD, veno-occlusive disease, immunodeficiency, infections, bleeding complications, acute organ failure, delayed organ dysfunctions including growth and development, endocrine functions, and effect on neurocognitive function

• Management of patients undergoing hematopoietic stem cell transplant and immunocompromised patients' hematological and immunological recovery, prevention of management of graft versus host disease, effects of chronic GVHD and other late effects of procedure of transplantation.

Clinical and histopathological changes with GVHD and use of drugs and procedures appropriate for the treatment of CGvHD.

• Implementation of all the guidelines for the care of immunocompromised patients including limiting environmental exposures to microorganisms by proper isolation measures, maintenance of the patients in a proper air-handled environment, and administration of prophylactic antimicrobial therapy.

• The knowledge of the Stem cell procurement process, which includes the evaluation of the patient for suitability for the procedure, the consenting process for the procedure, collection of the product (Bone Marrow harvest under general anaesthesia or collection of the peripheral blood stem cells by apheresis procedure) and evaluation of the product collected

v. Gene Therapy

vi. Monoclonal Antibodies in Pediatric Hematology and Oncology

vii. Biological Response Modifiers

viii. Management of Oncologic Emergencies

ix. Supportive Care of Patients with Cancer

x. Nutritional Assessment and Intervention

xi. Palliative and Supportive Care

xii. Evaluation, Investigations & Management of Late Effects of Childhood Cancer

xiii. Psycho-Social Aspects of Managing Oncologic Patients

xiv. Childhood Cancer in Low-Income and Middle-Income Countries in the Twenty-First Century

xv. Cancer Registries and the Descriptive Epidemiology of Pediatric Cancer in Low-and Middle-Income Countries

xvi. The Role of International Organizations on Collaboration for Global Pediatric Cancer Control

xvii. The Role of Twinning Programs and Telemedicine in Pediatric Oncology

xviii. Paediatric Radiotherapy

xix. Central Venous Catheters

xx. Management of Fever in the Child with Cancer

xxi. Acute Pain Management in the Inpatient Setting

xxii. Palliative Care

xxiii. Chemotherapy Basics

xxiv. Guide to Procedures

xxv. Treatment of Chemotherapy Extravasations

xxvi. Biostatistics, Research Methodology and Clinical Epidemiology

xxvii. Ethics

xxviii. Medico-legal aspects relevant to the discipline

xxix. Health Policy issues as may apply to the discipline

Career Options

After completing FNB Paediatric Haemato-Oncology, candidates will get employment opportunities in Government and the Private sector.

In the Government sector, candidates have various options to choose from which include Junior research fellow, Teaching at academic medical centres, and Consultants.

While in the Private sector, the options are Fellow (Paediatric Haemato-Oncology), Junior research fellow, Senior Research fellow (Paediatric Haemato-Oncology), and Consultants.

Frequently Asked Questions (FAQs) –FNB Paediatric Haemato-Oncology Course /FNB in Paediatric Haemato-Oncology Course

Answer: The full form of FNB is Fellow of National board.

Answer: FNB in Paediatric Haemato-Oncology or Fellow of National Board in Paediatric Haemato-Oncology is a doctoral fellowship program for doctors in India that is done by them after completion of their postgraduate medical degree course.

Answer: FNB in Paediatric Haemato-Oncology is a fellowship program of two years.

Answer: The candidate should have a DNB or MD (Paediatrics) degree obtained from any college/university recognized by the Medical Council of India (Now NMC)/NBE. The prerequisite requirements mentioned here are as of 2022. For any further changes, please refer to the NBE website.

Answer: FNB Paediatric Haemato-Oncology offers candidates various employment opportunities and career prospects.

• Question: What is the average salary for an FNB Paediatric Haemato-Oncology candidate?

Answer: The FNB Paediatric Haemato-Oncology candidate’s average salary is between Rs.22 lakhs to Rs. 46 lakhs per annum depending on the experience.

Answer: Yes, the candidate can teach in a medical college/hospital after completing the fellowship.